Pharmaceutical Robots Market : Benefits Offered By Robotic Systems In Pharmaceutical Manufacturing

Pharmaceutical Robots Market

Major Growth Boosters:
Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Download PDF Brochure:

Expected Revenue Growth:
[141 Pages Report] The overall pharmaceutical robotic systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021

What This Report Will Provide?
As the demand for new drugs and medicines grows, pharmaceutical companies are continuously looking for new ways to increase productivity, leading to an increased reliance on automated equipment and robotics.
Robotic systems provide various benefits to pharmaceutical manufacturing such as lesser space utilization, reduced production downtime, no labor turnover, enhanced health and safety, better waste management, increased production flexibility, improved production output and product quality, and lower operating costs. With the growing pharmaceutical industry and the various benefits offered by robotic automation, the adoption of robots is likely to increase in the coming years.

The following are the major objectives of the study.
•       To describe and forecast the pharmaceutical robotic systems market, in terms of value, by type, application, and region
•       To describe and forecast the pharmaceutical robotic systems market, by region–Asia Pacific (APAC), Europe, North America, and Rest of the World (RoW) along with their respective countries
•       To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and challenges)
•       To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
•       To study the complete value chain of pharmaceutical robotic systems
Major Market Developments
•       In 2016, Kawasaki opened a Tokyo Robot Center Showroom in Odaiba, Tokyo, Japan. The new facility offers robotics-related information.
•       In 2016, Yaskawa launched the MOTOMAN-MH5BM, a six-axis vertical articulated robot. The robot is ideal for sterile or hygienic environments such as the biomedical field, which includes drug discovery research, pharmaceutical and medical industry, as well as the beverage industry.
•       In 2016, FANUC collaborated with NVIDIA (U.S.) to implement Artificial Intelligence on the FANUC Intelligent Edge Link and Drive (FIELD) system. This is aimed to increase robotics productivity and bring new capabilities to automated factories across the globe. Moreover, the advances in artificial intelligence aim to allow robots to watch & learn, and improve its capabilities.
•       In 2016, Mitsubishi established two new Factory Automation (“FA”) centers in Italy and South Africa. With this expansion, the company aimed at expanding the FA product support network in Southern Europe and Africa, along with strengthening and accelerating local customer service.

Request Sample Report:

Picking and Packaging
Automation is becoming an increasingly important part of pharmaceutical manufacturing. A robotic system is a type of automation. Robots offer various advantages, such as high efficiency, save workers from hazardous environments and repetitive tasks, reduce training overheads, eliminate human errors, and increase repeatability and reproducibility. The common applications of robots include pick and place operations that often use SCARA robots

Regional Growth Analysis:
The pharmaceutical robotic systems market in APAC is expected to grow at the highest CAGR during the forecast period owing to factors such as the increase in domestic industrial robots companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investments and funding in the industrial robots industry, and Japan’s Robot Strategy.

About MarketsandMarkets
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441